MINNEAPOLIS, May 09, 2023 (GLOBE NEWSWIRE) -- Relievant Medsystems, a company dedicated to transforming the diagnosis and treatment of vertebrogenic…
Funds raised from Sterling Partners will be used to further innovative research and expand access to cutting-edge careCHICAGO, May 09,…
ST. LOUIS, May 09, 2023 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for…
MOUNTAIN VIEW, Calif., May 09, 2023 (GLOBE NEWSWIRE) -- G-Tech Medical, a developer of non-invasive diagnostic solutions for patients with…
OCALA, Fla., May 09, 2023 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), an immuno-pharma company…
BOSTON, May 09, 2023 (GLOBE NEWSWIRE) -- Cerevance, a private, clinical-stage drug discovery and development company focused on developing novel…
- Children in the ELPIS I trial had 100% survival up to 5 years of age after receiving Lomecel-BTM compared…
Follows successful evaluation by Dr. Jimmy D. Huebert, MD, including Epidural Steroid Injection (ESI) procedures in lumbar, thoracic and cervical…
BILLERICA, Mass., May 09, 2023 (GLOBE NEWSWIRE) -- SeqLL Inc. (“SeqLL” or the “Company”) (NASDAQ: SQL; SQLLW), a technology company…
- Upcoming clinical and regulatory milestones remain on track with previous guidance – - Current cash, cash equivalents and short-term…